300 related articles for article (PubMed ID: 20698245)
1. In vitro chemosensitivity of gastric adenocarcinomas to histone deacetylase inhibitors, compared to established drugs.
Yoon SN; Roh SA; Cho DH; Kim MB; Hyun YL; Ro S; Kim BS; Kim SY; Kim YS; Kim JC
Hepatogastroenterology; 2010; 57(99-100):657-62. PubMed ID: 20698245
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer.
Kim JC; Shin ES; Kim CW; Roh SA; Cho DH; Na YS; Kim TW; Kim MB; Hyun YL; Ro S; Kim SY; Kim YS
Anticancer Res; 2009 Aug; 29(8):3027-34. PubMed ID: 19661311
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay.
Kim JC; Kim DD; Lee YM; Kim TW; Cho DH; Kim MB; Ro SG; Kim SY; Kim YS; Lee JS
Int J Colorectal Dis; 2009 Feb; 24(2):209-18. PubMed ID: 18830613
[TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo.
Tumber A; Collins LS; Petersen KD; Thougaard A; Christiansen SJ; Dejligbjerg M; Jensen PB; Sehested M; Ritchie JW
Cancer Chemother Pharmacol; 2007 Jul; 60(2):275-83. PubMed ID: 17124594
[TBL] [Abstract][Full Text] [Related]
5. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ
Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of histone deacetylase 2 is found in human gastric cancer.
Song J; Noh JH; Lee JH; Eun JW; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
APMIS; 2005 Apr; 113(4):264-8. PubMed ID: 15865607
[TBL] [Abstract][Full Text] [Related]
8. Lung adenocarcinoma is more sensitive than gastric adenocarcinoma to anticancer drugs in vitro.
Kohnoe S; Moriguchi S; Emi Y; Sakaguchi Y; Maehara Y; Ishida T; Mitsudomi T; Sugimachi K
Eur J Surg Oncol; 1991 Feb; 17(1):47-50. PubMed ID: 1995357
[TBL] [Abstract][Full Text] [Related]
9. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
11. Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors.
Naldi M; Calonghi N; Masotti L; Parolin C; Valente S; Mai A; Andrisano V
Proteomics; 2009 Dec; 9(24):5437-45. PubMed ID: 19834889
[TBL] [Abstract][Full Text] [Related]
12. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
[TBL] [Abstract][Full Text] [Related]
13. Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma.
Kaiser M; Lamottke B; Mieth M; Jensen MR; Quadt C; Garcia-Echeverria C; Atadja P; Heider U; von Metzler I; Türkmen S; Sezer O
Eur J Haematol; 2010 Apr; 84(4):337-44. PubMed ID: 20028416
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R
Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro].
Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633
[TBL] [Abstract][Full Text] [Related]
16. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
[TBL] [Abstract][Full Text] [Related]
17. [Effects of pirarubicin chemotherapy combined with hyperthermia on gastric cancer in vitro].
Wang XG; Fu J; Zheng H; Li GX; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1487-90. PubMed ID: 17062359
[TBL] [Abstract][Full Text] [Related]
18. Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells.
Sato T; Suzuki M; Sato Y; Echigo S; Rikiishi H
Int J Oncol; 2006 May; 28(5):1233-41. PubMed ID: 16596240
[TBL] [Abstract][Full Text] [Related]
19. In vitro antitumor activity of 4'-O-tetrahydropyranyladriamycin on human gastric cancer cells.
Yamaue H; Tanimura H; Noguchi K; Shono Y; Iwahashi M; Hotta T; Tani M; Tsunoda T; Nishimoto N; Terasawa H; Nakamori M
Anticancer Res; 1996; 16(1):243-6. PubMed ID: 8615614
[TBL] [Abstract][Full Text] [Related]
20. Identification of tumor and invasion suppressor gene modulators in bladder cancer by different classes of histone deacetylase inhibitors using reverse phase protein arrays.
Gould JJ; Kenney PA; Rieger-Christ KM; Silva Neto B; Wszolek MF; LaVoie A; Holway AH; Spurrier B; Austin J; Cammarata BK; Canes D; Libertino JA; Summerhayes IC
J Urol; 2010 Jun; 183(6):2395-402. PubMed ID: 20403623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
